Literature DB >> 18218340

Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

Fabio Marra1, Amalia Gastaldelli, Gianluca Svegliati Baroni, Gianluca Tell, Claudio Tiribelli.   

Abstract

Non-alcoholic steatohepatitis (NASH), a cause of cirrhosis and hepatocellular carcinoma, is characterized by fatty infiltration of the liver, inflammation, hepatocellular damage and fibrosis. Progress has been made in understanding the molecular and cellular mechanisms implicated in the pathogenesis of this condition, therefore, we here review recent developments regarding the basic mechanisms of NASH development. Accumulation of triglycerides in the hepatocytes is the result of increased inflow of free fatty acids and de novo lipogenesis. Steatosis leads to lipotoxicity, which causes apoptosis, necrosis, generation of oxidative stress and inflammation. The resulting chronic injury activates a fibrogenic response that leads eventually to end-stage liver disease. A better understanding of these mechanisms is crucial for the design of novel diagnostic and therapeutic strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18218340     DOI: 10.1016/j.molmed.2007.12.003

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  157 in total

1.  Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.

Authors:  Jian-Hong Chu; Hui Wang; Yan Ye; Ping-Kei Chan; Si-Yuan Pan; Wang-Fun Fong; Zhi-Ling Yu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Establishment of a mouse model of enalapril-induced liver injury and investigation of the pathogenesis.

Authors:  Yuji Shirai; Shingo Oda; Sayaka Makino; Koichi Tsuneyama; Tsuyoshi Yokoi
Journal:  Lab Invest       Date:  2017-03-06       Impact factor: 5.662

3.  The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

Authors:  Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

4.  Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.

Authors:  Kouichi Miura; Yuzo Kodama; Sayaka Inokuchi; Bernd Schnabl; Tomonori Aoyama; Hirohide Ohnishi; Jerrold M Olefsky; David A Brenner; Ekihiro Seki
Journal:  Gastroenterology       Date:  2010-03-27       Impact factor: 22.682

5.  Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice.

Authors:  Wai Han Yiu; Chi-Jiunn Pan; Paul A Mead; Matthew F Starost; Brian C Mansfield; Janice Y Chou
Journal:  J Hepatol       Date:  2009-02-05       Impact factor: 25.083

Review 6.  Fatty liver in childhood.

Authors:  Yesim Ozturk; Ozlem Bekem Soylu
Journal:  World J Hepatol       Date:  2014-01-27

7.  MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.

Authors:  Tianpeng Zhang; Junjie Hu; Xiaomei Wang; Xiaoling Zhao; Zhuoyu Li; Junqi Niu; Clifford J Steer; Guohua Zheng; Guisheng Song
Journal:  J Hepatol       Date:  2018-09-13       Impact factor: 25.083

8.  A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).

Authors:  Jyoti Srivastava; Chadia L Robertson; Kareem Ebeid; Mikhail Dozmorov; Devaraja Rajasekaran; Rachel Mendoza; Ayesha Siddiq; Maaged A Akiel; Nidhi Jariwala; Xue-Ning Shen; Jolene J Windle; Mark A Subler; Nitai D Mukhopadhyay; Shah Giashuddin; Shobha Ghosh; Zhao Lai; Yidong Chen; Paul B Fisher; Aliasger K Salem; Arun J Sanyal; Devanand Sarkar
Journal:  Hepatology       Date:  2017-06-30       Impact factor: 17.425

Review 9.  Insulin resistance and neurodegeneration: roles of obesity, type 2 diabetes mellitus and non-alcoholic steatohepatitis.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Jack R Wands
Journal:  Curr Opin Investig Drugs       Date:  2009-10

10.  Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy; Kelli A Lytle
Journal:  Proc Nutr Soc       Date:  2015-08-18       Impact factor: 6.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.